#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	2690	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2799	234.9	0	.	n	.	0	C451T	SNP	451	451	C	1068	1068	T	340	T,C,G,A	186,142,2,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	2690	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2799	234.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1801	1801	C	279	C,A	271,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	2690	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2799	234.9	0	HET	.	.	.	C207T	.	207	207	C	824	824	C	219	C,T	175,26	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	5658	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4259	330.5	0	.	n	.	0	T695C	SNP	695	695	T	1434	1434	C	362	C,T,G	352,5,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	5658	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4259	330.5	0	.	n	.	0	T1971C	SNP	1971	1971	T	2710	2710	C	430	C,G,A	418,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	5658	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4259	330.5	1	SNP	n	A2045G	0	.	.	2045	2045	A	2784	2784	A	417	A,C	406,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	5658	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4259	330.5	1	SNP	n	C2597T	0	.	.	2597	2597	C	3336	3336	C	465	C,T,A	452,2,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	5658	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4259	330.5	0	HET	.	.	.	A1638G	.	1638	1638	A	2377	2377	A	389	A,G	210,173	.	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	712	folP	855	855	100.0	folP.l15.c4.ctg.1	2201	79.7	1	SNP	p	R229S	1	.	.	685	687	AGC	1358	1360	AGC	97;98;101	A;G;C	94;98;100	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1142	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	4030	69.8	1	SNP	p	S91F	1	.	.	271	273	TTC	885	887	TTC	60;61;61	T;T,C;C	54;56,1;60	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1142	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	4030	69.8	1	SNP	p	G95N	0	.	.	283	285	GGC	897	899	GGC	63;63;63	G;G;C	62;61;61	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1142	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	4030	69.8	1	SNP	p	D95G	1	.	.	283	285	GGC	897	899	GGC	63;63;63	G;G;C	62;61;61	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	568	mtrR	633	633	100.0	mtrR.l6.c4.ctg.1	1903	74.1	1	SNP	p	G45D	0	.	.	133	135	GGC	784	786	GGC	120;120;120	G;G;C	115;114;116	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	372	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1555	59.2	0	.	n	.	0	A197.	DEL	197	197	A	852	852	A	103	A	103	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1240	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3540	86.7	1	SNP	p	D86N	0	.	.	256	258	GAC	920	922	GAC	89;90;94	G,C;A,T;C,A	73,1;68,1;78,1	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1240	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3540	86.7	1	SNP	p	S87R	1	.	.	259	261	CGT	923	925	CGT	94;94;95	C,A;G;T	86,1;74;86	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1240	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3540	86.7	1	SNP	p	R87I	0	.	.	259	261	CGT	923	925	CGT	94;94;95	C,A;G;T	86,1;74;86	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1240	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3540	86.7	1	SNP	p	R87W	0	.	.	259	261	CGT	923	925	CGT	94;94;95	C,A;G;T	86,1;74;86	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1240	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3540	86.7	1	SNP	p	S88P	0	.	.	262	264	TCC	926	928	TCC	95;94;94	T,G;C,T;C	81,1;83,2;90	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	986	parE	1986	1986	100.0	parE.l6.c4.ctg.1	3489	69.9	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1946	1948	GGC	82;84;84	G;G;C	74;71;72	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	800	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2686	72.6	1	SNP	p	A311V	0	.	.	931	933	GCC	1566	1568	GCC	110;110;110	G,T;C,A;C,G	107,1;107,1;106,2	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	800	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2686	72.6	1	SNP	p	I312M	1	.	.	934	936	ATG	1569	1571	ATG	110;108;108	A,G,C;T,C;G,A	107,1,1;107,1;106,1	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	800	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2686	72.6	1	SNP	p	T316P	0	.	.	946	948	ACC	1581	1583	ACC	105;105;104	A,G,T;C,A;C,A	96,3,1;103,1;102,2	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	800	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2686	72.6	1	SNP	p	V316T	1	.	.	946	948	ACC	1581	1583	ACC	105;105;104	A,G,T;C,A;C,A	96,3,1;103,1;102,2	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	800	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2686	72.6	1	SNP	p	T483S	0	.	.	1447	1449	ACC	2082	2084	ACC	97;97;97	A;C;C,A	95;90;94,1	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	800	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2686	72.6	1	SNP	p	A501V	0	.	.	1501	1503	GCG	2136	2138	GCG	96;96;96	G;C,T;G	89;86,1;89	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	800	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2686	72.6	1	SNP	p	A501P	0	.	.	1501	1503	GCG	2136	2138	GCG	96;96;96	G;C,T;G	89;86,1;89	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	800	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2686	72.6	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2259	2261	GGT	76;76;75	G,A,T;G,T,A;T,G	72,2,1;71,3,1;74,1	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	800	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2686	72.6	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2268	2270	AGC	69;70;70	A,C;G,T;C,G	51,1;58,1;58,2	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	800	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2686	72.6	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2286	2288	CCG	56;54;54	C;C,G;G,C	44;37,3;44,1	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1360	ponA	2397	2397	100.0	ponA.l6.c4.ctg.1	3704	90.9	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1936	1938	CCG	128;128;128	C,G,A;C,A;G,C,T	108,1,1;117,2;92,3,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	490	porA	1146	1146	99.91	porA.l15.c4.ctg.1	2426	50.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	907	907	C	50	C,G	40,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	458	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	2183	52.2	1	SNP	p	G120K	1	.	.	358	360	AAG	929	931	AAG	54;54;51	A,C;A;G,A	51,1;52;47,1	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	458	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	2183	52.2	1	SNP	p	N121D	0	.	.	361	363	AAC	932	934	AAC	51;51;51	A;A;C	49;50;50	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	458	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	2183	52.2	1	SNP	p	A121N	1	.	.	361	363	AAC	932	934	AAC	51;51;51	A;A;C	49;50;50	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	1112	rpoB	4179	4179	99.98	rpoB.l6.c4.ctg.1	5463	50.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	122	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1395	21.8	1	SNP	p	V57M	1	.	.	169	171	ATG	796	798	ATG	43;42;42	A;T;G	39;42;42	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
